Skip to content
McDermott+ cover art

All Episodes

McDermott+ — 300 episodes · page 3 of 3

#
Title
201

Congress Focuses on Telehealth

202

In Depth: Laboratory-Developed Tests Final Rule

203

House Facing Another Motion to Vacate?

204

Nursing Staff Minimum Standards Final Rule

205

Congress Focuses on Change Healthcare and Medicaid Access

206

Deeper Dive on the Medicaid HCBS Access Final Rule

207

Foreign Aid and Proposed Rules

208

FY 2025 IPPS Proposed Rule

209

Healthcare in Congress This Week - It's Time for Change

210

Congressional Leaders Reach Agreement on Draft National Privacy Standard

211

Congress Flips Its Calendar to 2024

212

Celebrating a Decade of McDermottPlus

213

Looking Ahead: 2024 Legislative Agenda

214

Site-Of-Service Patterns Vary by Geography

215

Another Round of Funding Bills

216

Congressional Review Act, Explained

217

Budget Week

218

Regulatory Implications of the Minibus Healthcare Package

219

Healthcare Provisions in the Minibus: What Was (and Wasn't) Included

220

Congressional Appropriators Reach a Deal

221

Another Funding Deadline Approaches

222

Site Neutral Payment Policies for Ambulatory Services

223

House Republicans and Government Funding

224

Black History Month Health Spotlight

225

Chiefs Winning, Chiefs Leaving

226

2024 Health Policy Outlook: Consumer Protections and Prescription Drugs

227

How Is Congress Using Their Time?

228

2024 Health Policy Outlook: Access to Care and Innovation

229

Ready, Set, Appropriations

230

Prior Authorization Final Rule

231

Congress Buys More Time

232

The Physician Conversion Factor "Doc Fix"

233

Congressional Funding: Same as It Ever Was

234

2024 Health Policy Outlook: Medicare and Medicaid Payment Coverage

235

Congressional Funding Fight

236

New Year, Same Congressional Uncertainty

237

Health Policy Year in Review

238

Medicaid Unwinding

239

Lower Costs, More Transparency Act Vote

240

Increasing Competition to Lower Rx Drug Prices

241

December Congressional Countdown: What to Expect

242

Remote Monitoring and Digital Therapies

243

No Legislative Deadline in December: What's Next?

244

Giving Thanks to Congress but Eyeing Upcoming Deadlines

245

MDMA Reimbursement and Health Policy Conference Takeaways

246

Continuing Resolution(s)?

247

Final Rules and Health Equity

248

11 Days Until Next Government Funding Deadline

249

AI Executive Order

250

House Back to Business, Shutdown Still Looms

251

Welcome Parashar Patel

252

Congressional Priorities and Speaker Uncertainty

253

In Depth: Organ Procurement and Transplantation Network (OPTN)

254

Still No Speaker

255

Navigating the New No Surprises Act Announcements

256

House Speaker Vote

257

Deeper Dive on FDA's LDT (Laboratory Developed Tests) Proposed Rule

258

Wait – No Shutdown?

259

In Depth: Site-neutral Payments

260

Shutdown Coming?

261

CPT (Current Procedural Terminology) and Why It Matters

262

12 Days Left to Avoid a Shutdown

263

Artificial Intelligence in Healthcare

264

House Returns with Transparency Bill

265

Q4 Health Policy Legislative Preview

266

September Already?

267

Recent Developments in Drug Payment Reform & Transparency

268

Federal IDR Process Update

269

Some Hospitals Could See Medicare Payments Decrease Under New Policy

270

Telehealth Policies in the 2024 Physician Fee Schedule Proposed Rule

271

Highlights of the CY 2024 Physician Fee Schedule Proposed Rule

272

Committee Action as August Recess Looms

273

In Depth: CMS OPPS & ASC Payment System Proposed Rule for CY 2024

274

Two Weeks Until August Recess

275

The Administration Takes on Surprise Billing

276

PAHPA Reauthorization Debate

277

Welcome Jeffrey Davis

278

Congressional Calendar Crunch

279

Welcome Leigh Feldman

280

Appropriations in the House & Senate

281

CMS Health Equity Conference Recap

282

Can House Republicans Find Unity?

283

In Depth: CMS Physician Fee Schedule Conversion Factor

284

Health Policy in the Wake of the Debt Limit

285

The Substance of the Debt Limit Bill

286

Debt Limit Deal Reached: What's Next?

287

Welcome Chris Salmen

288

Debt Limit Deadlock Continues

289

Analyzing the House E&C Health Bill Markup

290

Debt Limit Debate Continues

291

The PHE Ends: What's Next?

292

Debt Limit Talks Continue & the End of the COVID-19 PHE

293

PBMs in the Spotlight

294

A Busy Week in Congress

295

Debt Ceiling, Committees and Courts

296

Previewing the Energy & Commerce Hearing on Healthcare Costs

297

+Dx Diagnostics Forum Top Takeaways

298

Previewing Wednesday's HHS Budget Hearing

299

The COVID-19 Pandemic Turns Three

300

Budget Season